Cellipon293™, a novel in vitro cationic lipid transfection reagent, is specifically developed for the delivery of DNA/RNA into HEK-293 cells as well as broad mammalian cells. With high transfection efficiency, low cytotoxicity, and simple protocol, Cellipon293™ enables researchers to get satisfactory results easy and fast. At $98.40 /mL, the cost is about about 30% of the price of major-brand products’ price.
America Pharma Source LLC
(240) 632-9478; www.apharmas.com
